| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.46B | 39.37B | 36.27B | 32.68B | 31.10B | 27.81B |
| Gross Profit | 8.94B | 9.75B | 8.12B | 6.57B | 6.22B | 6.07B |
| EBITDA | 4.60B | 4.52B | 4.39B | 3.42B | 3.03B | 2.49B |
| Net Income | 2.56B | 2.91B | 2.39B | 1.78B | 1.40B | 1.05B |
Balance Sheet | ||||||
| Total Assets | 21.34B | 23.99B | 22.49B | 20.06B | 17.52B | 16.24B |
| Cash, Cash Equivalents and Short-Term Investments | 5.20B | 6.62B | 5.68B | 5.92B | 5.07B | 4.91B |
| Total Debt | 1.90B | 1.00B | 1.95B | 2.55B | 2.13B | 2.73B |
| Total Liabilities | 7.76B | 8.74B | 8.87B | 8.05B | 7.09B | 6.79B |
| Stockholders Equity | 13.51B | 15.19B | 13.55B | 11.95B | 10.38B | 9.40B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.96B | 3.39B | 1.25B | 1.60B | 1.72B |
| Operating Cash Flow | 0.00 | 3.06B | 3.56B | 1.42B | 1.65B | 1.84B |
| Investing Cash Flow | 0.00 | -271.35M | -2.28B | -233.18M | -360.39M | -9.40M |
| Financing Cash Flow | 0.00 | -2.33B | -1.51B | -432.38M | -1.28B | -1.89B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥25.19B | 15.44 | ― | 2.18% | 9.87% | 40.32% | |
78 Outperform | ¥34.15B | 10.88 | ― | 3.40% | 8.54% | 20.57% | |
77 Outperform | ¥28.73B | 8.18 | ― | 2.93% | 7.86% | 28.33% | |
74 Outperform | ¥27.92B | 16.05 | ― | 2.45% | 13.49% | 12.99% | |
69 Neutral | ¥30.60B | 13.32 | ― | 2.22% | 11.22% | 55.88% | |
65 Neutral | ¥30.17B | 10.75 | 10.34% | 4.82% | -2.83% | 5.48% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |